Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
These results suggest that MCQ-based benchmarks may significantly overstate AI competence and that the "sycophancy gap" in large models pose a unique risk for misinformation
During the Super Bowl, telehealth platform Hims & Hers released a controversial ad calling out drugmakers that provide weight loss drugs priced for profits, not patients. It then proceeded to highlight its compounded GLP-1 offerings, calling them affordable, doctor-trusted and formulated in the USA. Shortly after, Novo Nordisk responded to the ad with its own Check before you inject campaign, highlighting the argument that patients should be wary of compounded GLP-1s given that they arent FDA-approved products
As a result, the FDA has recommended against the use of compounded GLP-1 medications, despite making it legal to sell them
Rapid GLP-1 weight loss often leaves loose skin and softened contours across the face (often referred to as Ozempic face), neck, jawline, and body
Medical knowledge evolves continuously, and information that is current at time of publication may become outdated as new research emerges
